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ABSTRACT 
 
Study Objective: To examine the effectiveness of PNF along with 
conventional therapy in improving Lung function in Bronchial asthma. 
 
Participants: 40 subjects with chronic asthma were selected. They were 
divided into control group and experimental group with 20 patients each. 
Outcome measure: The outcome measurement is done by peak 
expiratory flow meter (PEFM) and Borg dyspnea scale (MRC) and inch 
tape. 
Result: Both groups showed significant improvement in lung function 
after the therapy program .The experimental group showed a statistically 
significant improvement in pulmonary function when compared to the 
control group at 5 % level of significance. 
 
Conclusion: Treatment with PNF  along with conventional physiotherapy 
showed a significant improvement in Thoracic expansion, PEFR and 
dyspnea than control group. A well designed trial is needed to study the 
effectiveness of  PNF in improving lung function in a large  group and to 
know its long term effect. 
 
Keywords: PNF, Chronic Asthma, Dyspnoea, PEFR, Thoracic 
expansion. 
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CHAPTER-I 
1.1 INTRODUCTION  
 Asthma is a chronic inflammatory disorder of the airways in which many cells and 
cellular elements play a role. In susceptible individuals, inflammation causes recurrent 
episodes of wheezing, breathlessness, chest tightness and cough partially at night and early 
morning. These episodes are usually associated with wide spread but variable out flow 
obstruction that is often reversible either spontaneously or with treatment. 
 
 Asthma is an inflammatory disorder of the airway in which many cells and cellular 
elements plays a critical role. 
  
Asthma is a disease of airway that is characterized by increased responsiveness of 
tracheal -bronchial tree to a multiplicity of stimuli. 
 
American thoracic society (1987) defined asthma as a lung disorder with following 
characteristics: 
? Airway obstruction that is reversible either 
spontaneously or with treatment. 
? Increase airway responsiveness to a variety of 
stimuli. 
 
This definition has changed the focus of attention towards the importance of airway 
inflammation from the previous belief of primary bronchial constriction. 
 
Asthma is chronic disorder of the chest leads neuromuscular skeletal changes and 
thereby affecting the neurological physiology of respiration. 
. 
Respiratory system which is naturally controlled by chemical and neural receptors. In 
diseased state the reduced neural receptors functions leads to decreased neuromuscular 
activity and properioceptive activity of thoracic cage. These new neuromuscular skeletal and 
proprioceptive factors lead to reduced respiratory movement and its function. 
 
Managing asthma is a challenging situation when it is acute or chronic. Naturally the 
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management of these patients needs a multidisciplinary team approach.  
 
The cost of bronchial asthma to the Australian community in 1991 was estimated to 
the up to 720 million of this cost to absenteeism in workers with bronchial asthma. 
 
 Public interest in non-pharmacological treatments of bronchial asthma.  The 
Australian physiotherapy association contents that physiotherapy management of bronchial 
asthma in conjunction with a multidisciplinary team can reduce the coast burden and side 
effects. 
 
 There is a high prevalence of asthma in the community, which has significant social 
and economic costs.  There is asthma evidence that appropriate exercise training and self 
management can reduce the burden of this disease. 
  
 In multidisciplinary team, physiotherapy play a vital role .Especially in Asthma, there 
is a repeated acute stages affecting in respiratory apparatus. 
 Physiotherapy prevents, maintains and improves the pulmonary function of the 
asthma patients. In that proprioceptive neuromuscular facilitation(PNF) gives a 
multidimensional activity of respiratory system may improves functions of respiratory 
system. 
 Even with advancement of physiotherapy,  we need a further research work on PNF 
on asthma patients. 
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1.2. NEED OF STUDY 
 In moderate to severe level of asthma disease, the severity significantly impairs the 
quality of life. Asthma in adult subject recognized to the poor quality of life. 
 So for the most burdening condition it can be treated by wide of intervention like 
bronchodilators therapy, diaphragmatic breathing exercise etc, here we concern about the 
treatment the proprioceptive neuromuscular facilitation.  
 Hence there is a need was felt to do further research work on PNF in improving 
pulmonary function if asthma patient  
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1.3. OPERATIONAL DEFINITION 
Asthma 
 Asthma is a clinical syndrome characteristic by wheezing and breathlessness and 
chest tightness.(Tidy’s physiotherapy)  
Dyspnea 
Shortness of breath, a subjective difficulty or distress in breathing, usually associated 
with disease of the heart or lungs; occurs normally during intense physical exertion or at high 
altitude. (Lippincott Williams & Wilkins) 
Peak expiratory flow rate 
The peak expiratory flow rate measures how fast a person can breathe out (exhale) air. 
It is one of many tests that measures how well the lungs are working.( Andrew Schriber) 
PNF Technique 
 Neurophysiologic facilitation is the terminology used to describe externally applied 
proprioceptive and tactile stimuli that produce reflex respiratory movement responses and 
that appear to alter the rate and depth of breathing. (Delva D Bethune 1976)                                                    
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1.4. AIM OF THE STUDY 
 To study the effectiveness of Proprioceptive neuromuscular facilitation techniques 
on improving pulmonary function in bronchial asthma. 
1.5. OBJECTIVE OF THE STUDY 
? To evaluate the effectiveness of PNF in asthmatics patient   
? To find out the effectiveness of PNF on improving dyspnea in asthmatic 
patient. 
? To find out the effectiveness of PNF on improving Thoracic expansions in 
asthmatic patient. 
? To find out the effectiveness of PNF on improving peak expiratory flow 
volume (PEFR) in asthmatic patient. 
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1.6. HYPOTHESIS 
Null hypothesis  
 There is no significant difference of PNF technique on improving dyspnea in asthma 
patient. 
  There is no significant difference of PNF technique on improving thoracic expansion 
in asthma patient. 
  There is no significant difference of PNF technique on improving PEFR in asthma 
patient.  
Alternate Hypothesis  
 There is significant difference of PNF technique on improving dyspnea in asthmatic 
patient.  
 There is significant difference of PNF technique on improving thoracic expansion in 
asthmatic patient.  
 There is significant difference of PNF technique on improving PEFR in asthmatic 
patient.  
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CHAPTER-II 
 REVIEW OF LITERATURE 
Myers TR, Tomasio L .et.al.  (2011 ) 
 
Asthma is a multifactorial, chronic inflammatory disease of the airways. The 
knowledge that asthma is an inflammatory disorder has become a core fundamental in the 
definition of asthma. Asthma's chief features include a variable degree of air-flow obstruction 
and bronchial hyper-responsiveness, in addition to the underlying chronic airways 
inflammation. This underlying chronic airway inflammation substantially contributes to 
airway hyper-responsiveness, air-flow limitation, respiratory symptoms, and disease 
chronicity.  
 
JuMukherjee AB, Zhang Z .et.al.  ( 2011) 
 
Allergic asthma is a chronic airway inflammatory disease in which exposure to 
allergens causes intermittent attacks of breathlessness, airway hyper-reactivity, wheezing, and 
coughing. Allergic asthma has been called a "syndrome" resulting from a complex interplay 
between genetic and environmental factors. In  asthma, an initial exposure to allergen results 
in T(H)2 cell-dependent stimulation of the immune response that mediates the production of 
IgE and cytokines. Re-exposure to allergen then activates mast cells, which release mediators 
such as histamines and leucocytes that recruit other cells, including T(H)2 cells, which 
mediate the inflammatory response in the lungs. 
 
Jeanne E. Moorman.MS  et.al. (2007) 
 
Asthma is an chronic respiratory disease with episodic symptoms, increased in 
prevalence during 1980--1996 in the United States. Asthma has been the focus of numerous 
provider interventions (e.g., improving adherence to asthma guidelines) and public health 
interventions during recent years. Although the etiology of asthma is unknown, adherence to 
medical treatment regimen and environmental management should reduce the occurrence of 
exacerbations and lessen the hardship of this disease. CDC has outlined a public health 
 8
approach to asthma that includes comprehensive analyses of national surveillance data on 
prevalence, health-care use and mortality, and a strategy to improve 
 
ORC Macro et al 2004  
 
Asthma is an chronic inflammatory lung disease characterized by recurrent episodes 
of breathlessness, wheezing, and coughing. From 1980 through 1996, the number of 
Americans afflicted with asthma more than doubled to almost 15 million. Learning how to 
manage asthma as a chronic disease is a major challenge for people with asthma and their 
families. Naturally the management of these patients needs a multidisciplinary team approach 
.In multidisciplinary team physiotherapy play a vital role in Asthma.   
 
A Huntely .et.al (2001)   
 
Bronchial asthma is an multifactorial disease in which environmental, infectious, 
allergic, and psychological elements all play a part. There is evidence that emotional stress 
can either precipitate or exacerbate both acute and chronic asthma. Whatever precipitates an 
asthmatic attack, anxiety is likely to accompany it. So that identification risk factor of asthma 
is very important when treating the asthma patients. 
Lee Larungrayab.D .et.al (2009)  
 Chest physical therapy like proprioceptive neuromuscular facilitation has an 
important role in a medical team to assist in resolving the critical problems deriving from 
chronic lung disease. The inability to be weaned off a ventilator does not only result from 
secretion production or muscle weakness, but other conditions including chest stiffness or 
immobility. The procedure to increase chest mobility includes specific chest stretching and 
mobilizations are useful for improving the pulmonary function and chest expansion. 
Putt MT, Watson m (2008)  
 
Chest muscle stretching techniques increase the vital capacity and range of motion in 
asthma patient. The hold and relax technique to the pectoralis major compared with the sham 
technique produced significant effects on vital capacity and upper-limb range of motion. Here 
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was no significant effect  on perceived dyspnea, or respiratory rate. So the stretching 
techniques very useful for improving the vital capacity of asthma patient. 
 
R. Revelette, S. Reynolds .et.al ( 1992)  
Their results indicate that increases in the activity of diaphragmatic tendon organs are 
associated with moderate increases in abdominal pressure and are likely the result of 
elevations in the active tension developed by the diaphragm. Combined with results from 
previous studies, it is possible that diaphragmatic tendon organs may play a role in the 
attenuation of respiratory muscle activation when abdominal pressure is increased. 
Jeremy Weedon PhD  et al (2007) 
 
Thoracic respirathoracic respiratory excursion is one such measurement of mobility. It 
is useful in diagnosing and evaluating asthma, chronic obstructive pulmonary disease 
(COPD), and thoracic scoliosis. In most of the asthma patient the thoracic expansion is less  
due impaired chest mobility .Its measured by inch tape in the three region of chest like axilla 
level, nipple level and xphoid process level. Chest expansion measurement is very useful for 
find out the prognosis of asthma when treating the asthma patient. 
 
 
Romagnoli . I et al ( 2011)  
  
 Chest wall displacement was in proportion to increased ventilation. Chest 
wall dynamic hyperinflation nor dyssynchronous breathing were major contributors to 
dyspnea. Chest wall expansion and ventilation were adequately coupled with each other. 
Montaldo et al ( 2000)  
 The greater thoracic expansion might improve the length  tension ration of the 
respiratory muscle decrease the afferents  stimuli for central respiratory control and reduce  
the dysponea. 
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Compel and Howell (1990)  
 In Asthma the mechanism of the lung or thoracic cage are affected. So the anterior 
and posterior diameter of the chest wall is less in asthma patient. 
 
Daniel R Neuspiel .et.al (2011) 
  
 The efficacy of peak flow rate monitoring for improving asthma outcome. Most 
studies have shown a benefit when peak flow rate monitoring is linked to a comprehensive 
program, combined with symptom diaries and patient education. 
 
Gregory sawacki, lienan haver .et.al (2010) 
 Peak expiratory flow measurement is a simple and inexpensive means of monitoring 
airway responsiveness, However peack flow monitoring is affect technique dependent, and 
there are concern with patient compliance and accounts reporting of peak flow data. 
 
J.Stephen Huff .et.al (2001) 
 
  Peak expiratory flow rate (PEFR) assessment or other spirometric measures were 
useful in clinical decision-making for patients with acute exacerbations of asthma. PEFR may 
aid emergency physicians during their evaluation and treatment of an adult patient with an 
acute exacerbation of asthma. Now days PEFR in measured by Wright expiratory flow meter. 
With help of the values of expiratory flow meter we can find out the severity of asthma. 
 
Parente AA, March MF .et al.(2011) 
Seven factors appeared to measure three dimensions of dyspnea: sensory (difficulty 
breathing and phase of respiration, depth and frequency of breathing, urge to breathe, 
wheeze), affective (chest tightness, anxiety), and behavioural (refraining from physical 
activity) dimensions. Difficulty breathing and phase of respiration occurred more often in 
COPD, followed by asthma Urge to breathe was unique for patients with medically 
unexplained dyspnea . Wheeze occurred most frequently in asthma, followed by COPD and 
 11
heart failure . Chest tightness was specifically linked to medically unexplained dyspnea and 
asthma . Anxiety characterized medically unexplained dyspnea . Refraining from physical 
activity appeared more often in heart failure, pulmonary vascular disease, and asthm 
Scano et al (2010) 
 They mention that unsatisfied inspiration are the dominant qualitative descriptors in 
patients with a variety of respiratory diseases. It is possible that sensory feedback from a 
multitude of mechanoreceptors throughout the respiratory system collectively convey 
information to the consciousness that volume/flow or chest wall displacement is inadequate 
for the prevailing respiratory drive. The data would lend support to the idea that: (i) an altered 
afferent proprioceptive peripheral feedback signals that ventilatory response is inadequate to 
the prevailing motor drive, reflecting neuromechanical uncoupling (ii) mechanical constraints 
on volume expansion  play a pivotal role in dyspnea causation in patients with asthma  
Furgał M, Nowobilski R, et al (2009) 
 A relationship can be observed between the functioning of the asthmatic patient's 
family and the severity of the patient's declared dyspnea. Dyspnea constitutes a specific form 
of emotional communication in the inter-spouse relationships.  An analysis of the severity of 
dyspnea in asthmatic patients should take into account the context of the functioning of the 
patient's family. 
Kahisali  et all (1999)  
 The elongation of the respiratory muscle might improve the thoracic expansion and 
decrease dysponea in Asthma patient..  
Prasad et al 2000 
 The usual means of assessing the subjective elements of breathlessness are the 
modified Borg scale of perceived breathlessness. 
 
 
 
 
 12
CHAPTER-III 
 MATERIAL AND METHIDOLOGY 
3.1. MATERIL USED 
? Low couch 
? Pillows 
? Chair 
? Foot stool 
? Assessment chat 
? Inch tape 
? Wright’s peak flow meter 
? Dysponea scale 
 
3.2. METHIDOLOGY 
3.2.1. Study deign 
A comparative study with pretest and post test. 
3.2.2. Sampling deign 
The randomized sampling techniques was used in this study. 
3.2.3. Sample size 
The sample size consists of 40 subjects with asthma. 
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3.2.4. Criteria for selection   
Inclusion criteria. 
? male patient 
? Age group 40 to 50 years 
? Sub acute and chronic asthma patient 
? Co-operative subjects 
Exclusion Criteria 
? Patient with cardio pulmonary pathology of cor- pulmonae 
? Subject with infected lung disease like TB 
? Cardiovascular disease 
? Cognition impairment 
? Loco motor disability 
? Pregnancy 
3.2.5. Study setting 
The study was conducted at  
1) Ashwin hospital, kovai 
2) Kovai Respiratory care centre, Coimbatore 
3.2.6. Study method  
The sample size consists of 40 subjects with asthma were selected and assigned in to two 
groups:  
   1)Controlled group 
   2) Experimental group 
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3.2.7. Duration of the study 
Duration of the treatment for one patient is 3 weeks. And total duration of study was 5 
month.  
3.2.8. Parameters  
? Wright’s peak expiratory flow meter 
? Inch tape 
? Borg scale 
3.2.9. Statiscal tools 
All the statically analysis were done using student-test. 
The formula for the t test 
t-test  
 
 
 
 d = difference between the pre and post test 
 d = mean difference  
 n = Total number of subjects  
 S = Standard calculation.  
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 The unpaired t-test f was used to compare statically significant difference in the 
dependent valuables between the two groups.    
Unpaired  ‘t’test 
 
 
 n1 = Total number of subject in controlled group 
n2 = Total number of subject in experimental group 
1x  = Mean of control group 
2x = Mean of experimental group 
 S = Standard deviation 
3.2.10. Techniques 
FOR CONTROL GROUP 
1.Chest mobility exercise 
 
To mobilize one side of the chest:. 
  
 While sitting, the patients bends away from the tight side to lengthen tight structures 
and expand that side of the chest during inspiration. Then, have the patient push the fisted 
hand into the lateral aspect of the chest, as he  bends toward the tight side and breathes out. 
Progress by having he patient raise the arm on the tight side of the chest over the head and 
side bend away from the tight side and repeat for 10 times. 
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To mobilize the upper chest and stretch the pectoralis muscles. 
  
  The patient is seated in a chair with hands clasped behind the head, and  horizontally 
abduct the arms (elongating the pectoralis muscles) during a deep inspiration 
 
2.Diapharamatic breathing exercise 
  
 Patients sit comfortably, with loose garments. Place one hand on chest and one on  
stomach. Asked the to Slowly inhale through nose or through pursed lips (to slow down the 
intake of  breath).while inhale, push belly/ stomach out and feel the stomach expand with  
hand.Sowly exhale through pursed lips to regulate the release of air while squeezing stomach. 
Repeat for 5 times. 
 
3.Relaxation position 
 Educate the patients regarding the relaxed positions to be adopted during an attack of 
breathlessness. 
? Unassisted Standing Positions 
? Unassisted Standing Positions 
? Unassisted Sitting Positions 
? Assisted Sitting Positions 
? High Side Lying 
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FOR EXPERIMENTAL GROUP 
1.Perioral  pressure 
 Perioral stimulation is provided by applying firm maintained pressure to the upper lip. 
Pressure is maintained for 5 second  and repeated for 10 times 
Observation: 
? increased epigastric excursion  
? deep breathing  
? sighting  
? swallowing  
? spout phenomena 
2. Vertebal pressure  
  Manual pressure is applied with the open hand directly over the upper most thoracic 
vertebrae to lower thoracic vertebrae. A pressure is maintained for 10 second and repeats it 
for 10 times. 
Observation:  
? increased epigastria excursion 
?  deep breathing 
3. Anterior stretch basal lift:  
Patient in supine position hands under posterior lower ribs and the lift gently upward 
and the stretch is maintained for 10 seconds 
Observation  
? Expansion posterior or basal area of chest  
? The increased epigastric movement  
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4. Co- contraction of abdomen 
 This is performed by the therapist placing one hand on the patient’s lower ribs and 
one on the pelvis same side and pushing  with moderate pressure and is maintained for 10 
seconds .The same procedure also doing in the opposite side also. An repeat for 10 times. 
Observation  
? Increased epigastric movement 
? Increased  muscle  contraction 
? Depression umbilicus  
 5. Stretching of pectrolis muscle 
 Instruct participant to sit on floor or bench and place hands behind head, facing 
forward. Stand behind participant and position leg behind their head. Place hands on 
participant's elbows. 
  Execution 
? Pull patient elbows back. Hold stretch for 5 second and repeat 
for 5 times. 
6. Intercostal stretch   
  This is produced by applying pressure to the upper border of ribs in order to stretch 
the intercostal muscle in a downward direction. Stretch position is maintained for 5 sercond 
and repeat for 10 times. 
    Observation:  
? Increased movement of the area being stretch 
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7. Moderate manual pressure  
The patient is in forward lean position with their arm supported high on pillow and 
their head resting on their arms for comfort. Mild pressure of the open hand is maintained 
over the posterior chest wall and maintain for 15 second. Repeat for 10 times.  
 Observation 
? Increased movement of the area being stretched 
3.2.11. Treatment Procedure 
 Total number of 30 patients who satisfies inclusion criteria was recruited for the 
study. Before starting the treatment general cardio respiratory assessment was takes from all 
the patient.   
 In addition dysponea rating through modified Borg scale, chest expansion, peak flow 
expiratory rate also measured for the all patients. Instruction is given to the patient about the 
treatment procedure. 
 The total number 40 subjects were separated into two groups control group and 
experiment group. The control group underwent the conventional physiotherapy like 
breathing exercise, relaxation techniques, and chest mobility exercise. The experimental 
group under went conventional physiotherapy and PNF techniques. 
Chest expansion is measured in the three region of chest .They are  
(i) Axilla  level  
  (ii) Nipple level 
  (iii) Xyphoid process level  
The peach expiratory flow rate is calculate by Wright peak expiratory flow meter. To 
perform a peaks expiator flow:- 
? stand up straight  
? make sure the indicator is at the bottom of the meter  
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? Take the deep breath filling your lung completely.  
? Place the mouth piece in your mouth, brightly  bite with your teeth, 
and close your lips on it.  
? Blast the air out as hard and as fast as possible in a single blow. 
? Record the numbers that appear on the meter  
? Repeat these step three times and recording the highest of the three 
readings in on asthma diary.  
The post test value of dyspnea, chest expansion, PEFR from both groups are recorded 
and documented. And the data was interpreted  for statistical analysis.   
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CHAPTER-IV 
DATA PRESENTATION 
TABLE-1 
DATA REPRESENTATION DYSPNEA IN CONTROLLED AND 
EXPERIMENTAL GROUP 
S. No 
CONTROLLED GROUP  EXPERIMENTAL GROUP 
Pre test Post test Pre test Post test 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
5 
7 
8 
8 
6 
7 
9 
6 
10 
5 
5 
10 
8 
7 
8 
8 
5 
5 
6 
7 
 
 
3 
5 
5 
6 
4 
5 
6 
4 
7 
3 
3 
8 
5 
4 
5 
4 
3 
2 
4 
4 
6 
8 
10 
7 
9 
5 
5 
6 
8 
7 
8 
10 
7 
6 
5 
8 
7 
7 
9 
9 
 
1 
3 
4 
2 
3 
0.5 
0.5 
0.5 
4 
2 
3 
4 
2 
2 
0.5 
3 
2 
2 
3 
3 
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DATA REPRESENTATION OF CHEST EXPANSION AT LEVEL 
OFAXILLA IN CONTROLLED AND EXPERIMENTAL GROUP 
 
TABLE-2 
 
S. No 
CONTROLLED GROUP EXPERIMENTAL GROUP 
Pre test Post test Pre test Post test 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
85 
88 
86 
89 
92 
90.5 
91 
95 
88 
87.5 
93 
89 
89.5 
94 
94.5 
93 
87 
90.5 
88 
93 
86 
90 
87.5 
90.5 
93.5 
91.5 
92 
96.5 
89.5 
88.5 
94 
90 
91 
95.5 
96.5 
94.5 
88.5 
92.5 
89.5 
94 
 
86 
87 
85 
90 
92 
86 
88 
93 
94.5 
92 
89.5 
91 
91 
95.8 
95 
89.5 
92 
93.5 
86 
90 
89 
90.5 
89.5 
94.5               
95.5 
89.5 
92 
96 
98 
94.5 
95.5 
95 
95 
99.5 
99 
93.5 
94.5 
97.5 
90.5 
94 
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DATA REPRESENTATION OF CHEST EXPANSION AT LEVEL OF 
NIPPLE  IN CONTROLLED AND EXPERIMENTAL GROUP 
 
TABLE-3 
 
S. No 
CONTROLLED GROUP EXPERIMENTAL GROUP 
Pre test Post test Pre test Post test 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
81 
84 
82 
86.5 
88 
85.5 
86 
89.5 
84 
81 
88.5 
85.5 
85 
88.5 
90 
93.5 
82 
84.5 
83 
88 
82.5 
86 
83.5 
88 
90 
87 
88.5 
91 
86.5 
83 
90.5 
87 
87 
90 
92.5 
95 
85 
86 
85 
91 
82 
81 
79 
83 
88 
82 
82.5 
88 
89 
85 
84. 
85 
85 
93.5 
89 
83.5 
92 
86.5 
81 
85 
 
87 
87 
83.5 
88 
92 
87 
87 
92.5 
93 
89 
90 
90 
91 
98.5 
95 
87.5 
96 
91.5 
86 
90 
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DATA REPRESENTATION OF CHEST EXPANSION AT LEVEL OF 
XPHOID IN CONTROLLED AND EXPERIMENTAL GROUP 
 
TABLE-4 
 
S. No 
CONTROLLED GROUP EXPERIMENTAL GROUP 
Pre test Post test Pre test Post test 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
77 
80 
78 
82 
84.5 
81 
82.5 
85.5 
80 
77 
82.5 
81 
81 
84.5 
85 
90.5 
79.5 
80 
80.5 
84 
79 
81 
80 
83.5 
86 
83.5 
84.5 
87 
82 
79 
85 
83 
82.5 
86.5 
87 
92 
81.5 
82 
83 
86 
79 
77.5 
75 
81 
84.5 
78 
78.5 
84 
85.5 
80 
81 
82 
82.5 
90 
86.5 
80 
90.5 
83 
78.5 
92 
84 
81 
79.5 
85.5 
89 
83 
83 
87.5 
89 
83 
83.5 
86 
86 
93 
89 
83.5 
94 
87 
82.5 
96 
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DATA REPRESENTATION OF PEFR  IN CONTROLLED AND EXPERIMENTAL 
GROUP 
      
     TABLE-5 
 
S. No 
CONTROLLED GROUP EXPERIMENTAL GROUP 
Pre test Post test Pre test Post test 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
 
260 
310 
280 
270 
300 
250 
270 
290 
300 
280 
290 
300 
250 
270 
250 
280 
290 
290 
260 
270 
 
300 
350 
320 
330 
350 
300 
330 
340 
350 
320 
330 
340 
310 
330 
320 
340 
340 
350 
320 
320 
270 
260 
300 
260 
250 
290 
300 
290 
290 
280 
260 
260 
270 
280 
290 
260 
250 
280 
260 
290 
360 
340 
450 
340 
330 
380 
400 
380 
370 
360 
350 
350 
360 
380 
380 
360 
350 
370 
360 
390 
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CHAPTER-V 
DATA ANALSIS AND INTERPRETATION 
TABLE-6 
 
PRE AND POST TEST VALUE OF DYSPNEA IN CONTROLLED GROUP 
S. No Controlled group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 7 
0.32 34.92 
2. Post test 4.5 
 
The calculated ‘t’ value between pre versus post exercise session of controlled group 
was 34.92 at 0.05%  which is greater than tabulated value (2.095). The result showed that 
there is a significant difference in pre and post test values. 
TABLE-7 
PRE AND POST TEST VALUE OF DYSPNEA IN EXPERIMENTAL GROUP 
S. No Experimental group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 7.35 
0.64 35.62 
2. Post test 2.25 
 
The calculated ‘t’ value between pre versus post exercise session of experimental  
group was 35.62 at 0.05% which is greater than tabulated value (2.095). The result showed 
that there is a significant difference in pre and post test values, and also controlled group 
value. 
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TABLE-8 
POST TEST VALUE OF DYSPNEA IN CONTROLLED AND EXPERIMENTAL 
GROUP 
S. No High Intensity group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 4.5 
1.31 
 
5.42 
 
2. 
Post test 2.25 
 
The calculated ‘unpaired t’ value between post versus post exercise session of 
controlled and experimental  group was 5.42 at 0.05% which is greater than tabulated value 
(2.048). The result showed that there is a significant difference.  
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GRAPH-1 
GRAPHICAL REPRESENTATION OF DYSPNEA  
0
1
2
3
4
5
6
7
8
controlled group expeimental group
Pre test
post test
 
 
 
 
 29
TABLE -9 
PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE AXILLA LEVEL 
IN CONTROLLED GROUP 
S. No Controlled group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 90.5 
.34 11.32 
2. Post test 92.5 
 
The calculated ‘t’ value between pre versus post exercise session of controlled group 
was 11.32 at 0.05% which is greater than tabulated value (2.095). The result showed that 
there is a significant difference in pre and post test values. 
TABLE -10 
 PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL 
OF AXILLA  IN EXPERIMENTAL GROUP 
S. No Experimental group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 90.55 
0.77 18.77 
2. Post test 94.38 
 
The calculated ‘t’ value between pre versus post exercise session of experimental 
group was 18.77 at 0.05% which is greater than tabulated value (2.095). The result showed 
that there is a significant difference in pre and post test values and also pre test value. 
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TABLE -11 
 POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL OF AXILLA  
IN CONTROLLED AND EXPERIMENTAL GROUP 
S. No  Group Mean 
Standard 
Deviation 
‘t’ Value 
1. Controlled group 92.5 
3.38 2.59 
2. Experimental group 94.38 
 
The calculated ‘t’ value between post  versus post exercise session of controlled 
group and experimental group was 2.59 at 0.05% which is greater than tabulated value 
(2.021). The result showed that there is a significant difference. 
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GRAPH-2 
GRAPHICAL REPRESENTATION OF CHEST EXPANSION IN THE AXILLA 
LEVEL 
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TABLE -12 
 PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE LEVEL OF 
NIPPLE  IN CONTROLLED GROUP 
S. No Controlled group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 85.95 
0.54 17.19 
2. Post test 87.75 
 
The calculated ‘t’ value between pre versus post exercise session of controlled group 
was 17.19  at 0.05% which is greater than tabulated value (2.095). The result showed that 
there is a significant difference in pre and post test values  
TABLE -13 
 PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE LEVEL OF 
NIPPLE IN EXPERIMENTAL GROUP 
S. No Experimental  group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 85.52 
.53 37.70 
2. Post test 90.8 
 
The calculated ‘t’ value between pre versus post exercise session of experimental 
group was 37.70  at 0.05% which is greater than tabulated value (2.095). The result showed 
that there is a significant difference in pre and post test values.  
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TABLE -14 
 POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL OF NIPPLE  
IN CONTROLLED  AND EXPERIMENTAL GROUP 
S. No Group Mean 
Standard 
Deviation 
‘t’ Value 
1. Controlled group 87.75 
3.37 2.19           
2. Experimental group 90.0 
 
The calculated ‘ unpaired t’ value between post versus post exercise session of 
controlled and experimental was 2.19 at 0.05% which is greater than tabulated value (2.048). 
The result showed that there is a significant difference. 
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GRAPH-3 
GRAPHICAL PRESENTATION OF CHEST EXPANSION IN  NIPPLE LEVEL 
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TABLE -15 
 PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL 
XPHOID PROCESS IN CONTROLLED GROUP 
S. No Controlled group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 81.8 
0.43 19.75 
2. Post test 87.8 
 
The calculated ‘t’ value between pre versus post exercise session of controlled group 
was 19.75 at 0.05% which is greater than tabulated value (2.095). The result showed that 
there is a significant difference in pre and post test values  
 
TABLE -16 
 PRE AND POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL 
OF XPHIOD PROCESS IN EXPERIMENTAL  GROUP 
S. No Experimental group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 82.45 
0.73 23.26 
2. Post test 89.8 
 
The calculated ‘t’ value between pre versus post exercise session of experimental 
group was 23.26 at 0.05% which is greater than tabulated value (2.095). The result showed 
that there is a significant difference in pre and post test values. 
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TABLE -17 
 POST TEST VALUE OF CHEST EXPANSION AT THE  LEVEL OF XPHIOD 
PROCRESS IN EXPERIMENTAL AND  CONTROLLED GROUP 
S. No  Group Mean 
Standard 
Deviation 
‘t’ Value 
1. Controlled group 87.8 
3.82 2.11 
2. Experimental group 89.8 
 
The calculated ‘unpaired t’ value between post versus post exercise session of 
controlled group was 2.11 at 0.05% which is greater than tabulated value (2.021). The result 
showed that there is a significant difference. 
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GRAPH-4 
GRAPHICAL REPRESENTATION OF CHEST EXPANSION IN THE LEVEL OF 
XPHOID PROCESS  
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TABLE -18 
PRE AND POST TEST VALUE OF PEFR IN CONTROLLED GROUP 
S. No Controlled group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 275 
9.33 24.75 
2. Post test 329 
 
The calculated ‘t’ value between pre versus post exercise session of controlled group 
was 24.75 at 0.05% which is greater than tabulated value (2.095). The result showed that 
there is a significant difference in pre and post test values  
 
TABLE -19 
PRE AND POST TEST VALUE OF PEFR IN EXPERIMENTAL GROUP 
S. No Experimental group Mean 
Standard 
Deviation 
‘t’ Value 
1. Pre test 276 
16.05 26.60 
2. Post test 368 
 
The calculated ‘t’ value between pre versus post exercise session of experimental 
group was 26.60 at 0.05% which is greater than tabulated value (2.095). The result showed 
that there is a significant difference in pre and post test values and also controlled group 
value. 
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TABLE -20 
 POST TEST VALUE OF PEFR IN EXPERIMENTAL AND CONTROLLED 
GROUP 
S. No  Group Mean 
Standard 
Deviation 
‘t’ Value 
1. Controlled group 329 
7.02 17.33 
2. Experimental group 368 
 
The calculated ‘unpaired t’ value between post versus post exercise session of 
controlled group and experimental was 17.33 at 0.05% which is greater than tabulated value 
(2.021). The result showed that there is a significant difference. 
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GRAPH-5 
GRAPHICAL REPRESENTATION OF PEFR  
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CHAPTER-VI 
 DISCUSSION 
Asthma is the most commonest harmful effect of respiratory system, for which 
pulmonary physiotherapy program is very much essential. 
 
This study was aimed to find out the effectiveness of the PNF on improving 
pulmonary function on asthma patient. In which shows improvement on dyspnea, chest, 
expansion and PEFR  in asthma patients. 
 
 For this study 40 subjects were selected using purposive sampling technique and were 
assigned into 2 groups, controlled and experimental group with 20 subjects in each. 
 
Control group patient were treated with conventional physiotherapy techniques such 
as breathing exercise, relaxation position, chest mobility exercise and experimental group 
were treated with conventional physiotherapy along with PNF techniques like pectorlis 
stretch, muscle, perioral pressure, intercostals stretch, vertebral pressure, co-contraction of 
the abdomen, anterior stretch basal lift and manual moderate pressure. 
In asthma patient the shape of thorax, posture and lung volumes are often deviate 
from the normal. The rib cage is held in a position of hyper inflation. This is frequently 
associated with some degree of thoracic kyphosis. The abdomen is often lax and muscles in 
the make appear strongly involved with respiration. Grimby et al believed that in asthma and 
chronic lung disease the diaphragm tends to be shortened aggressively, that is to say that as 
the end respiratory lung volume is increased, the diaphragm tend to be nearly function less in 
some patient due to its shortening and flattening. Campbell and Howell have proposed that 
length tension in appropriate of respiratory muscles may be a contributing factor to dyspnea. 
In controlled group the treatment like breathing exercise, relaxation techniques and 
chest mobilization exercises are given and the values are documented in the ‘t’ test. 
Diapharagmatic breathing exercise strengthen the diaphragm, Decrease the work of 
breathing by slowing your breathing rate, Decrease oxygen demand, Use less effort and 
energy to breath. So that dysnea is reduced. 
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Thoracic mobility exercises combine active movements of the trunk or extremities 
with deep breathing. These exercises combine stretching of the trunk muscles with deep 
breathing which improve ventilation and chest expansion 
Relaxation position is relive the compression of diapharam and also reduce the 
anxiety. So that the breathing pattern is improved and dyspnea is reduced. 
 The main objective of the PNF is to improve the mechanical stability of the 
respiratory system by effecting a change in posture and to improve the pattern of respiratory 
muscle by improving the abdominal muscle support to diaphragmatic function and reducing 
the activity in the muscle of neck. 
Perioral pressure as a procedure to reduce the spastic muscle tone (Marget Rood) and 
also improves generalized relaxation. The reduction of spastic muscle tone and improved 
relaxation causes more air entry into the lung and reduces the severity of dyspnea. 
Intercostals stretch produces the gradual increase in respiratory movement in the area 
under and around it. The stretch thus produced effective in restoring respiratory movement   
pattern and so to improve the chest expansion of the asthma patient. 
Vertebral pressure over the thoracic results improved diaphragmatic activity in 
response to high thoracic vertebral stimulation and facilitated apical respiratory activity 
following pressure over the lower thoracic region. The vertebral pressures mainly improve 
the epical respiratory movement so that the peak expiratory flow right, dyspnea and chest 
expansion are reduced. 
According to Rood the co-contraction of the abdomen also activate the diaphragm, 
abdominal return contractions. As applyed on the both side of abdomen this procedure 
produced the stretching of abdominal muscles this would activate the  muscle spindle and 
they in turn would cause their homogenous extrafusal muscle to contract. The contraction of 
these muscles would in turns stretch the abdominal muscle on the other side. Stretch would 
activate their on extrafusal muscle due to abdominal co-contration, there is increasing tone of 
the abdomen and the activation of diaphragm is occurred. Thus by ventilation is increased 
due to this PEFR is also increased. 
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In Anterior stretch based lift, it results in increasing the movement of the ribs in the 
lateral and posterior direction which can be seen and felt the thoracic expansion is improved 
by this stretch. 
The pectorlis major muscle stretch also improves the stretch expansion of chest by 
improving the length of pectorlis muscle. Manual moderate pressure over the posterior chest 
wall of asthma causes and excitation of inspiratory neuron .According to Sumi the expiratory 
field for the inspiratory motor neurons were more extensive than those of expiratory neurons, 
more inspiratory neuron can be excited by a single stimulus. So that the breathing pattern is 
improved and dyspnea also reduced. 
In dyspnea ,there is marked improvement in asthma patient after giving the PNF 
techniques  when compare to the controlled  group .The severity of dyspnea is less after 
giving the PNF .After 4 weeks of treatment the dyspnea is measured by Borg scale of 
dyspnea in both group and the  value is applied to the ‘t’ test. Their is marked improvement is 
found in both controlled and experimental group but greater significant is found experimental 
group  
In asthma patient the expiratory phase is more compare to inspiratory phase .so there 
is marked reduction  of chest expansion  in asthma patient .After completing the course of 
treatment the chest expansion is measured in the three region of chest and the value is 
statically analyzed. The chest expansion is improved in both group but greater significant is 
present in experimental group. 
Peak expiratory rate also significantly less in asthma patient .Peak expiratory flow 
rate is measured by Wright’s peak expiratory flow meter 
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CHAPTER - VII 
RESULT 
The purpose of the study was to examine the effectiveness of the Proprioceptive neuro 
muscular facilitation improves lung function in patients with asthma. The study used is an 
experimental study. The population included the patients diagnosed as asthma. Those patients 
were randomly assigned into control group and experimental group of 20 each. Control group 
received conventional physiotherapy including breathing exercises, relaxation techniques, 
and chest mobility exercises. The experimental group received PNF in addition to 
conventional physiotherapy. Pre-test evaluation was done on the first day prior to treatment 
and post test evaluation was done on the last day of treatment. The tools selected for 
measuring the outcome of the study were brog dyspnea scale, Wright expiratory flow meter 
for peak expiratory flow rate and inch tape for thoracic expansion. The values are statistically 
analyzed by‘t’ test.  
In dyspnea the mean post test score for experimental group 2.25 and mean post test 
score for experimental group is 7.35.”t” value obtained is 35.62 which statistically significant 
at 0.05% level. The mean of pretest score for controlled group is 7 and post test score is 4.5 
ant ‘value obtained is 34.92 which is statistically significant ta 0.05% level. Post score are 
greater than the pre values at 0.05% level of significance and also greater in experimental 
group. Data analysis shows significant improvement in dyspnea rates in experimental groups. 
This might be due to the cumulative effect of PNF techniques 
In chest expansion  the mean post test score for experimental group 94.38 and mean 
post test score for experimental group is 90.55 and ”t” value obtained is 18.77  which 
statistically significant at 0.05% level. The mean of pretest score for controlled group is 90.5 
and post test score is 92.5 ant ‘value obtained is 11.37 which is statistically significant ta 
0.05% level. Post score are greater than the pre values at 0.05% level of significance and also 
greater in experimental group. Data analysis shows significant improvement in chest 
expansion  in experimental groups. This might be due to the cumulative effect of PNF 
techniques 
Chest expansion in the level of nipple  the mean post test score for experimental 
group 87.75 and mean pretest score for experimental group is 85.95  and ”t” value obtained is 
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16.39  which statistically significant at 0.05% level. The mean of pretest score for controlled 
group is 85.52 and post test score is 90.08 and the ‘t ‘value obtained is 37.70  which is 
statistically significant ta 0.05% level. Post score are greater than the pre values at 0.05% 
level of significance and also greater in experimental group. Data analysis shows significant 
improvement in chest expansion in experimental groups. This might be due to the cumulative 
effect of PNF techniques 
Chest expansion in the level of  process, the mean post test score for experimental 
group 89.8 and mean pretest score for experimental group is 82.45  and ”t” value obtained is 
23.26  which statistically significant at 0.05% level. The mean of pretest score for controlled 
group is 81.88 and post test score is 87.8 and the ‘t ‘value obtained is 19.75 which is 
statistically significant ta 0.05% level. Post score are greater than the pre values at 0.05% 
level of significance and also greater in experimental group. Data analysis shows significant 
improvement in chest expansion  in experimental groups. This might be due to the 
cumulative effect of PNF techniques 
In PEFR, the mean post test score for experimental group 368  and mean pretest score 
for experimental group is 276  and ”t” value obtained is 26.60 which statistically significant 
at 0.05% level. The mean of pretest score for controlled group is 275 and post test score is 
329 and the ‘t ‘value obtained is 24.75 which is statistically significant ta 0.05% level. Post 
score are greater than the pre values at 0.05% level of significance and also greater in 
experimental group. Data analysis shows significant improvement in PEFR  in experimental 
groups. This might be due to the cumulative effect of PNF techniques 
In this study prove the PNF and conventional physiotherapy techniques are more 
effective than conventional physiotherapy techniques. So alternative hypothesis is accepted. 
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CHAPTER - VIII 
 
CONCLUSION 
 
  It can be concluded PNF may be useful in pulmonary rehabilitation of patients with 
bronchial asthma. This shows the greater potentiality towards the experimental group which 
indicated the importance of   PNF in asthma patients. 
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CHAPTER - IX 
 
 LIMITATIONS AND SUGGESTIONS 
 
 Limitations  
1. Size of the sample was very small. 
2. The study was of short duration. 
3. Frequency of attacks was not recorded. 
4. The researcher was not able to assess the other psychological parameters of the 
patients. 
 
  Suggestions  
1. A large sample size is required to explain more about effectiveness 
2. To make the result more valid, a long term study may be carried out. 
3. Regular home and follow up program can be included to know the long term effect of 
treatment. 
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CHAPTER – XII 
APPENDIX I 
ASSESSMENT FORM 
 
• Name: 
• Age: 
• Sex: 
• Occupation: 
• Chief complaints: 
• Address: 
• Hospital No.: 
• Referred doctor: 
• Diagnosis: 
• Reason for reference: 
HISTORY 
• History of present condition: 
Onset- 
Duration - 
Aggravating Factors-(Cause for increase in intensity)- 
Alleviating Factors-(Rest, remedial medications-use of inhalers or PUFFS,)- 
• Past medical history: 
• Personal history: 
• Smoking history: 
• Family history: 
• Psychosocial History: 
• Socioeconomic history: 
 
SUBJECTIVE EVALUATION OF CARDINAL SYMPTOMS: 
A.DYSPNOEA 
On strenuous activity: 
On ordinary activity: 
At Rest: 
B.WHEEZE 
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Diurnal Variations: 
Postural Variations: 
Aggravating Factors: 
C.COUGH 
Productive: 
Dry: 
Timing (at night, cold air, exercise,): 
D.SPUTUM 
Colour: 
Consistency: 
Quantity: 
E.EXTRIMITIES 
Edema: 
Cyanosis: 
Clubbing: 
 
 
OJECTIVE ASSESSMENT: 
ON OBSERVATION 
• General Appearance- 
• Skin- 
• Neck- 
• Jugular venous pressure- 
• Body Built- 
• Breathing Pattern:(Abdomino-thoracic or Thoraco –abdominal)- 
• Use of accessory muscles- 
• Shape of the chest wall- 
• Nutritional Status- 
VITAL SIGNS 
Temperature: 
Respiratory rate: 
Blood Pressure: 
Pulse rate: 
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ON INSPECTION 
A. Breathing pattern: 
• Rate, Depth, Rhythm- 
• Abdominothoracic / Thoracoabdominal- 
• Pursed lip breathing- 
B. Chest wall configuration: 
• Pectus excavatum- 
• Pectus carinatum- 
• Flail- 
• Chest expansion- 
C. Colour: 
D. Symmetry of chest movement: 
E. Clubbing fingers: 
F. Cyanosis: 
G. Intercostals in drawing: 
H. Chest wall scars, bruising, signs of trauma: 
I. Use of accessory muscles: 
ON AUSCULTATION 
A. Breath Sounds: 
a. Normal 
• Bronchial 
• Bronchovescicular 
• Vescicular 
b. Abnormal 
• Bronchial 
• Decreased 
• Absent 
c. Adventitious 
• Crackles 
• Wheeze and 
• Rhonchi 
B. Voice Sounds 
• Bronchophony 
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• Egophony 
• Whispering Pectoriloquy 
C. Extra pulmonary sounds 
• Pleural rub 
• Stridor 
ON PERCUSSION 
• Resonant: 
• Hyper resonant: 
• Dull: 
• Flat: 
ON PALPATION 
• Chest wall Tenderness: 
• Edema: 
• Respiratory excursion: 
• Tactile fremitus: 
• Tracheal  deviation: 
• Peripheral pulse: 
• Skin temperature and texture: 
 
INVESTIGATIONS 
• Imaging of the chest: 
• Pulmonary function test: 
• ABG(Blood Gases): 
• Sputum Examination: 
? Colour  
? Consistency  
? Volume. 
 
 
PROBLEM LIST: 
 
 
TREATMENT PLAN: 
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APPENDIX – II 
PATIENT CONSENT FORM 
 
TITLE: EFFECTIVENESS OF PNF ON IMPROVING PULMONARY  FUNCTION 
IN BRONCHIAL  ASTHMA 
INVESTIGATOR: _ _ _ _ _ _ _ _ _ _ _ 
PURPOSE OF THE STUDY: 
I_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ,have been informed that this study will work towards 
achieving on the functional activities of daily living in post-stroke conditions for me and 
other patients. 
PROCEDURE: 
Each term of the study protocol has been explained to me in detail. I understand that during 
the procedure, I will be receiving the treatment for one time a day. I understand that I will 
have to take this treatment for four weeks. 
I understand that this will be done under investigator, _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
supervision. I am aware also that I have to follow therapist’s instructions as has been told to 
me. 
CONFIDENTIALITY:    
 I understand that medical information provided by this study will be confidential. If the data 
are used for publication in the medical literature or for teaching purposes, no names will be 
used and other literature such as audio or video tapes will be used only with permission. 
RISK AND DISCOMFORT: 
I understand that there are no potential risks associated with this procedure, and understand 
that investigator will accompany me during this procedure. There are no known hazards 
associated with this procedure. 
REFUSAL OR WITHDRAWL OF PARICIPATION: 
I understand that the decision my participation is wholly voluntary and I may refuse 
participate, may withdraw consent at any time during the study. 
I also understand that the investigator may terminate my participation in the study at anytime 
after researcher has explained me the reasons to do so. 
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I _ _ _ _ _ _ _ _ _ _ _ _ _ _ have explained to …………………………………. the purpose of 
the research, the procedures required and the possible risks and benefits, to the best of my 
ability. 
……………………………………                         …………………………… 
Investigator                                               Date 
I ………………………………. Confirm that researcher has explained me the purpose of the 
research, the study procedure and the possible risks and benefits that I may experience. I have 
read and I have understood this consent to participate as a subject in this research project. 
……………………..                                          ………………………… 
Subject                                                         Date    
………………………..                                       …………………………. 
Signature of the Witness                          Date  
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APPENDIX-III 
SCALE FOR DYSNEA: 
O – Nothing it all 
O.5 - very  very slight 
1 – very slight 
2 – Slight 
3 – Moderate 
4 – Some what strong 
5 – Severe 
6 – 
7 – very severe 
8 – 
9 – very very severe 
10 –maximum 
 
 
